Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CRHBP | P24387 | 1/20 | 0.43 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | CASP7 | P55210 | 1/20 | 0.41 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.39 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.38 |
| ▸ | APP | P05067 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3426863 | 0.91 | ALDH1A1 (0.58) | ALDH1A1TDP1ADRA2BPTGS1CYP1A2 | |
| SCHEMBL13262147 | 0.88 | ALDH1A1 (0.45) | ALDH1A1TDP1ADRA2BPTGS1CYP1A2 | |
| Acetic Acid SCHEMBL2127698 | 0.88 | ALDH1A1 (0.45) | ALDH1A1TDP1ADRA2BPTGS1CYP1A2 | |
| SCHEMBL21693960 | 0.87 | ALDH1A1 (0.44) | ALDH1A1TDP1ADRA2BPTGS1CYP1A2 | |
| SCHEMBL30223435 | 0.86 | ALDH1A1 (0.56) | ALDH1A1TDP1ADRA2BPTGS1CYP1A2 | |
| SCHEMBL104725 | 0.86 | ALDH1A1 (0.56) | ALDH1A1TDP1ADRA2BPTGS1CYP1A2 | |
| SCHEMBL10584217 | 0.86 | ALDH1A1 (0.52) | ALDH1A1TDP1ADRA2BPTGS1CYP1A2 | |
| SCHEMBL872693 | 0.85 | ALDH1A1 (0.47) | ALDH1A1TDP1ADRA2BPTGS1CYP1A2 | |
| SCHEMBL19675242 | 0.85 | ALDH1A1 (0.52) | ALDH1A1TDP1ADRA2BPTGS1CYP1A2 | |
| SCHEMBL25429532 | 0.84 | ALDH1A1 (0.55) | ALDH1A1TDP1ADRA2BPTGS1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4222493-B1 | SCREENING TEST FOR CATSPER MODULATORS | UNIV MUENSTER WESTFAELISCHE WILHELMS (DE) | 2025-04-30 | — | — | EP | claimed |
| CN-114522157-A | Application of calcium ion chelating agent in preparation of preparation for improving phagocytic capacity of vascular endothelial cells | 重庆大学 | 2022-05-24 | — | — | CN | claimed |
| WO-2013052787-A2 | MEMBRANE ACTIVATED CHELATORS AND USE IN THE PREVENTION AND TREATMENT OF PARASITIC INFECTION | THE JOHNS HOPKINS UNIVERSITY (US) | 2013-04-11 | — | — | WO | claimed |
| EP-1546085-A4 | LIPOPHILIC DIESTERS OF CHELATING AGENT FOR INHIBITION OF ENZYME ACTIVITY | DPHARM LTD (IL) | 2008-03-26 | — | — | EP | claimed |
| EP-1546085-A2 | LIPOPHILIC DIESTERS OF CHELATING AGENT FOR INHIBITION OF ENZYME ACTIVITY | D-Pharm Ltd. (IL) | 2005-06-29 | — | — | EP | claimed |
| WO-2004028443-A2 | LIPOPHILIC DIESTERS OF CHELATING AGENT FOR INHIBITION OF ENZYME ACTIVITY | D-PHARM LTD. (IL) | 2004-04-08 | — | — | WO | claimed |
| WO-1997049386-A1 | ORAL DELIVERY OF PEPTIDES | PEPTIDE DELIVERY SYSTEMS PTY. LTD. (AU) | 1997-12-31 | — | — | WO | claimed |
| EP-0542790-A4 | — | PROMEGA CORP (US) | 1995-02-08 | — | — | EP | claimed |
| EP-0542790-A1 | METHOD AND KIT FOR THE SEPARATION, CONCENTRATION AND ANALYSIS OF CELLS | PROMEGA CORPORATION (US) | 1993-05-26 | — | — | EP | claimed |
| WO-1992000317-A1 | METHOD AND KIT FOR THE SEPARATION, CONCENTRATION AND ANALYSIS OF CELLS | PROMEGA CORPORATION (US) | 1992-01-09 | — | — | WO | claimed |
| US-12545698-B2 | Dinuclear platinum (II) red emitters for OLED applications | VERSITECH LIMITED (CN) | 2026-02-10 | — | — | US | disclosed |
| US-20240324441-A1 | DINUCLEAR PLATINUM (II) RED EMITTERS FOR OLED APPLICATIONS | VERSITECH LIMITED (CN) | 2024-09-26 | — | — | US | disclosed |
| EP-4347611-A1 | DINUCLEAR PLATINUM (II) RED EMITTERS FOR OLED APPLICATIONS | Versitech Limited (HK) | 2024-04-10 | — | — | EP | disclosed |
| CN-114522157-B | Application of calcium ion chelating agent in preparation of preparation for improving phagocytic capacity of vascular endothelial cells | 重庆大学 | 2023-08-15 | — | — | CN | disclosed |
| WO-2022253231-A1 | DINUCLEAR PLATINUM (II) RED EMITTERS FOR OLED APPLICATIONS | VERSITECH LIMITED (CN) | 2022-12-08 | — | — | WO | disclosed |
| US-5072046-A | Monomers for polyimides, polyamides and poly-urethanes | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1991-12-10 | — | — | US | disclosed |
| US-4534908-A | Water-soluble disazo compounds and new bis-(aminophenoxy)-ethane compounds having fiber-reactive groups as the tetrazo components, and use of the disazo compounds as dyestuffs | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-08-13 | — | — | US | disclosed |
| EP-0071168-B1 | WATER-SOLUBLE DISAZO COMPOUNDS AND BIS-(AMINO-PHENOXY)-ETHANE COMPOUNDS WITH FIBRE REACTIVE GROUPS AS TETRAZO COMPOUNDS, PROCESS FOR THE PREPARATION OF THESE COMPOUNDS AND THE USE OF THE DISAZO COMPOUNDS AS DYESTUFFS | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-01-30 | — | — | EP | disclosed |
| EP-0024702-B1 | DISAZO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS DYESTUFFS | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-02-16 | — | — | EP | disclosed |
| EP-0071168-A2 | Water-soluble disazo compounds and bis-(amino-phenoxy)-ethane compounds with fibre reactive groups as tetrazo compounds, process for the preparation of these compounds and the use of the disazo compounds as dyestuffs | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-02-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240324441-A1 | DINUCLEAR PLATINUM (II) RED EMITTERS FOR OLED APPLICATIONS | OCIAD2, POF1B, OCIAD1 | ALDH1A1 3841/4885TDP1 1917/4885ADRA2B 3739/4885 |
| US-12545698-B2 | Dinuclear platinum (II) red emitters for OLED applications | OPRD1, POF1B, OCIAD2 | ALDH1A1 3167/4885TDP1 3043/4885ADRA2B 2210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.